WTR Healthcare Happenings
WTR Healthcare Happenings is a weekly conversation with healthcare executives, medical experts, and investors on recent clinical data or industry-driving events in healthcare.
WTR Healthcare Happenings
Latest Episodes
Vivos Therapeutics, Inc. (VVOS): Deleveraging, Driving Referrals, and Building Toward Positive Cash Flow
In this episode of WTR Healthcare Happenings, Kirk Huntsman, CEO of Vivos Therapeutics (NASDAQ: VVOS), joins WTR healthcare analyst Robert Sassoon and host Tim Gerdeman to break down the company's financial and operational restructuring....
Natural MedTech: Why the Psychedelic Opportunity Starts With Manufacturing
In this episode of WTR Healthcare Happenings, Natural MedTech CEO and Co-Founder Luke McFarlane joins WTR healthcare analyst Robert Sassoon and Shawn Severson to discuss the company's biosynthetic psilocybin manufacturing platform and its posit...
Cannara Biotech (LOVFF): Gaining Share in the Canadian Cannabis Market
In this episode, Cannara Biotech COO and Interim CFO Nick Sosiak joins WTR's Linda Bolton Weiser and Tim Gerdeman to discuss the company's expansion following the announcement of a long-term international supply agreement with Curaleaf carrying...
Oncolytics Biotech (ONCY): A Differentiated Approach to Treating Gastrointestinal Cancers
In this episode of WTR Healthcare Happenings, Oncolytics Biotech CEO Jared Kelly joins WTR's Tim Gerdeman and healthcare analyst Robert Sassoon to discuss the company's progress advancing pelareorep, its investigational oncolytic virus immunoth...
The Psychedelic Inflection Point: Big Pharma, FDA, and the Next Wave of Brain Medicines
In this episode of WTR Healthcare Happenings, Doug Drysdale, biopharma veteran and founder of Katagen, former CEO of Cybin (now Helus Pharma), joins WTR's Tim Gerdeman and analyst Robert Sassoon to explore whether psychedelic medicine has moved...